Many in the field of reproductive biology, including ourselves, have published on studies of ''progesterone-induced proteins'' such as uteroferrin (Phosphatase, Acid, Type 5, TartrateResistant; ACP5) expressed by uterine glandular epithelium in several species. Another example is ''progesterone-induced'' genes expressed by uterine lumenal epithelium, such as plasmintrypsin inhibitor. Publication on ''progesterone-induced'' uterine proteins is not surprising as progesterone is, after all, the hormone of pregnancy required for establishment and maintenance of pregnancy in all mammals. However, results of research using state-of-the-art molecular techniques and attention to temporal and spatial (cell-specific) aspects of gene expression have revealed a paradox with respect to mechanisms of action of progesterone. The paradox is that uterine endometrial epithelia cease expressing receptors for progesterone and estradiol prior to implantation in all mammals studied, including humans, nonhuman primates, mice, shrew, spotted skunk, and domestic animals. In sheep, for example, loss of progesterone receptors in uterine lumenal and glandular epithelia occurs by Day 11 and Day 13 of the estrous cycle and pregnancy, respectively; however, endometrial stromal cells and myometrial cells express progesterone receptors throughout gestation. Similarly, progesterone receptors are minimal in the glandular epithelium, but retained in the stroma of the functionalis zone of the macaque during the mid-secretory phase corresponding to the window of implantation. The loss of progesterone receptors in uterine epithelia appears to be a prerequisite for implantation and differentiated functions of uterine epithelia directed by factors produced by stromal cells that do express progesterone receptors. In addition, loss of progesterone receptors by uterine epithelia is associated with reduced, modified, or lost expression of genes, such as the anti-adhesive protein MUC1, that may interfere with implantation.
Following the discovery that uterine epithelia of ewes do not express progesterone receptors after Days 11 to 13 of pregnancy, we determined that endometrial stromal cells express fibroblast growth factor 10 (FGF10) and hepatocyte growth factor (HGF), while the tunica intima of blood vessels express FGF7. These growth factors, collectively known as progestamedins, exert their effects via their respective receptors, fibroblast growth factor 2 IIIb splice variant (FGFR2(IIIb)) and met proto-oncogene (hepatocyte growth factor receptor) (MET) expressed by all uterine epithelia and conceptus trophectoderm in sheep. The differential spatial patterns of expression for FGF10 and FGF7 in ovine uteri suggest that they have independent roles in endometrial function. Fgf 7-null mice lack a phenotype, but Fgf10-null mice have many developmental deficiencies. FGF7 supports epithelial cell proliferation and differentiation to mediate effects of progesterone in the primate endometria, while FGF10 is a mesenchymal-derived growth factor essential for patterning branching and morphogenic events, including embryonic lung and limb bud formation. FGF7 and FGF10 are mitogens for epithelial cells, while HGF induces proliferation, motility, and morphogenesis of cells.
Progesterone also suppresses levels of uterine glandular estrogen receptor in most mammals, resulting in decreased expression of estrogen-dependent genes. In women estradiol inhibits integrin beta 3 (ITGB3), a marker of endometrial receptivity. The loss of estrogen receptors during the mid-secretory phase is correlated with increased ITGB3. Progesterone-induced loss of estrogen receptor further delineates the period in the menstrual cycle when glandular proliferation ceases and implantation can occur in women. In primates, progesterone-stimulated reduction of epithelial estrogen receptors occurs concomitantly with loss of epithelial progesterone receptor.
Loss of expression of progesterone and estrogen receptors by endometrial epithelia is a prerequesite for implantation, expression of genes for secretory proteins, and selective transport of molecules into the uterine lumen to create histotroph that is essential for conceptus growth and development. So, how does progesterone influence expression of these genes in the uterine epithelium? It seems clear that the effect cannot be via progesterone response elements in the genes by ligand-activated progesterone receptors binding to progesterone response elements in the promoter region of genes. Therefore, attention must be directed toward alternative mechanisms that include the following scenarios: (a) low levels of progesterone receptor, which remain after progesterone-induced down-regulation of progesterone receptor, may still be sufficient to maintain uterine gene expression; (b) progesterone may induce expression of progestamedins (e.g., FGF7, FGF10, HGF) by stromal cells that retain progesterone receptor, which in turn, exert paracrine effects on epithelia expressing FGFR2(IIIb) and MET.
Uterine receptivity to implantation involves multiple events, including: (a) silencing of progesterone receptor and estrogen receptor genes, (b) suppression of genes for immune recognition, (c) increased expression of genes for attachment of trophectoderm to the uterine lumenal and superficial glandular epithelia, (d) phenotypic modification/decidualization of uterine stromal cells, (e) alterations in membrane permeability to enhance conceptus-maternal exchange of regulatory factors and the transport of nutrients into the uterine lumen, and (f) a dramatic increase in endometrial vascularity. Ultimately these events culminate in endometrial receptivity as well as signaling for pregnancy recognition. Differential expression of genes by uterine epithelia and stromal cells in response to progesterone is considered essential for successful embryo implantation in most mammals. As reproduc-tive biologists, we must recognize that the so-called ''progesterone-induced'' phenotype is created by both the silencing of epithelial progesterone receptors and the concomitant stimulation by paracrine signaling pathways induced by stromal progestamedins via their respective receptors on uterine epithelia.
Consequently, the promoter regions of genes of interest must be interrogated for response elements to products of mitogen-activated protein kinase and phosphoinositide-3 kinase pathways if we are to understand regulation of endometrial receptivity. In the meantime, let's stop publishing results of studies that perpetuate the myth that progesterone acts via its nuclear receptors in uterine epithelia to directly stimulate gene expression.
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